Opinion of EXTI potential by poster
By: arubaviax10
18 Nov 2003, 11:39 AM EST
Msg. 15612 of 15677
Jump to msg. #
No One can deny the following facts:
1. This company has a guarantedd $18,000,000 over the next
7 years. This is the MINIMUM they will make. When the Pharmas do their DD on the Cell Lines, it is fair to say that the MAJORITY of the major PHARMA's will be using our product. So far, there have been ZERO problems with verifying the product.
2. In a comparison of debt then versus now, the company has been paying it down and this should not be a problem.
3. The company HAS BEEN ACTIVELY looking for a partner on its Sybiol Liver Device. This will bring in NEW revenue to
the company and this revenue will most likely enable the company to begin producing their Therapeutic Protein Product.
These three things simply point out that the company understands the potential. They are using their money well and are making the company much healthier. I still believe that we are looking at between $1 and $2 by the end of the year.
I expect to see upcoming PR's within the next 3 months centered around the following issues:
1. Contract from Roche
2. Contract from Asian Pharma.
3. Introduction and/or update on Therapeutic Protein Product.
4. Announcement of new partner in the Sybiol Liver device.
5. Issuance of Patent including revisions on Sybiol Liver Device.
6. Annual Report showing improving numbers but a very strong outlook.
7. Announcement of move to AMEX
Things will get much better over the next few months. All of the listed PR's above are within reach of the company.
I think we will be looking at a much happier New Year than any of us had in 2003.
AI
